Live Breaking News & Updates on Sandy Blauvelt

Stay updated with breaking news from Sandy blauvelt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA

Blauvelt discusses the future research of higher-dose risankizumab for patients with psoriasis and why it may be "disruptive in the treatment space." ....

United States , San Diego , Andrew Blauvelt , American Academy Of Dermatology , Oregon Medical Research Center , American Academy , Aad 2024 , Sandy Blauvelt ,

Rizankizumab and the KNOCKOUT Study, with Andrew Blauvelt, MD, MBA

Blauvelt discusses the impetus for his phase 2 trial looking at the ability to mitigate pivotal psoriasis memory T cells with risankizumab. ....

San Diego , United States , Andrew Blauvelt , American Academy Of Dermatology , Oregon Medical Research Center , American Academy , Psoriasis Area Severity Index , Aad 2024 , Sandy Blauvelt ,

Head-to-Head Studies for Plaque Psoriasis Therapies

Expert dermatologists highlight the benefits of head-to-head trials for various agents for the management of plaque psoriasis and review the top-line results of a study comparing risankizumab and apremilast. ....

Benjamin Lockshin , Sandy Blauvelt , Bruce Strober , Jennifer Soung , Plaque Psoriasis , Head To Studies , Skin Clearance Rates , Il 23 Inhibitors , Meta Analysis , Acumulative Effect ,

Dr Andy Blauvelt: Drug Approval, Accessibility Challenges in Treating Patients with AD

Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, discusses challenges many physicians face in getting approved for the most effective drugs to treat patients with atopic dermatitis (AD). ....

United States , Sandy Blauvelt , Oregon Medical Research Center , Oregon Medical Research ,